Register information Patent

DE file number : 60 2011 046 852.9 (Status: pending/in force, Query started: April 26, 2025)

Please note: This English version is a non-binding translation of the German register excerpt. Only the German version of the register excerpt is legally binding.

Master data
INIDCriterionFieldContent
Type of IP rightSARTPatent
StatusSTPending/in force
21DE file number DAKZ60 2011 046 852.9
96EP file numberEAKZ16 15 8434.7
97EP publication numberEPN3045467
54Designation/titleTIECHTZEITÜBERWACHUNG UND STEUERUNG VON PROTEINPRODUKTIONSVERFAHREN UNTER VERWENDUNG VON IMPEDANZSPEKTROSKOPIE
51IPC main classICM
(ICMV)		 C07K 1/14 (2006.01)
22DE application dateDATDec 9, 2011
96EP application dateEATDec 9, 2011
43Date of first publicationOTJul 20, 2016
Date of publication of grantPETMar 21, 2018
71/73Applicant/ownerINHTakeda Pharmaceutical Company Limited, Osaka-shi, Osaka, JP
72InventorINWauters, Cary, La Crescenta, CA 91214, US; Zaydenberg, Alexander, Woodland Hills, CA 91367, US
74RepresentativeVTRHoffmann Eitle Patent- und Rechtsanwälte PartmbB, 81925 München, DE
Address for service HOFFMANN - EITLE Patent- und Rechtsanwälte PartmbB, 81925 München, DE
33
31
32
Foreign priorityPRC
PRNA
PRDA
US
423891 P
Dec 16, 2010
Due dateFT
FG		Dec 31, 2025
Annual fee for the 15th year Patent fees
Patent division in charge 44
97EP language of publicationELANGEN - Englisch
84Designated EP contracting statesEDSAL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Published EP/WO documentsEPWOPNOriginal document: EP000003045467
Searchable text: EP000003045467
Original document: EP000003045467B1
Searchable text: EP000003045467B1
43Date of first publicationEVTJul 20, 2016
Date of the first transfer into DPMAregisterEREGTSep 2, 2016
Date of the (most recent) update in DPMAregisterREGTNov 30, 2024
(Show all update days)(Hide all update days)
  • Nov 30, 2024
    • Due date: changed
  • Nov 12, 2024
    • Representative: changed
  • Nov 29, 2023; Aug 31, 2023; Jul 27, 2023; Dec 3, 2022; Nov 24, 2021; Jul 15, 2021; Jun 5, 2021; Dec 1, 2020; Nov 26, 2020; Nov 23, 2019; Aug 16, 2019; Mar 14, 2019; Feb 7, 2019; Dec 4, 2018; Apr 19, 2018; Apr 12, 2018; Mar 13, 2018; Mar 8, 2018; Apr 6, 2017
    • Historical data not available for this/these date(s)
  • Sep 2, 2016
    • Date of the first transfer into DPMAregister
Procedural data
No.Kind of procedureLegal statusDate of legal/procedural statusPublication dateAlle Details anzeigen
1 Procedure relating to EP application EPO 1st publication Jul 20, 2016  Details anzeigen
2 Publications Publication of a mention regarding EP 1st publication by DPMA Sep 1, 2016 Sep 1, 2016 Details anzeigen
3 Procedure relating to EP application EPO publication of mention regarding patent grant (beginning of opposition period) Mar 21, 2018  Details anzeigen
4 Publications Publication by DPMA of mention regarding EP patent grant Apr 19, 2018 Apr 19, 2018 Details anzeigen
5 Procedure relating to EP application No opposition to patent grant filed, or opposition proceedings at EPO completed without decision Jan 2, 2019 Mar 14, 2019 Details anzeigen
6 New applicant/owner details New applicant/owner details Jun 4, 2021 Jul 15, 2021 Details anzeigen
7 New applicant/owner details New applicant/owner details Jul 26, 2023 Aug 31, 2023 Details anzeigen
View procedures Procedure relating to EP application (No.: 1)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTEPO 1st publication
Date of legal/procedural statusVSTTJul 20, 2016
View procedures Publications (No.: 2)
INIDCriterionFieldContent Close details
Type of procedureVARTPublications
Legal/procedural statusVSTPublication of a mention regarding EP 1st publication by DPMA
Date of legal/procedural statusVSTTSep 1, 2016
Issue numberHN35
YearPJ2016
Publication dateVTSep 1, 2016
Type of publicationPARTBibliographic data
View procedures Procedure relating to EP application (No.: 3)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTEPO publication of mention regarding patent grant (beginning of opposition period)
Date of legal/procedural statusVSTTMar 21, 2018
View procedures Publications (No.: 4)
INIDCriterionFieldContent Close details
Type of procedureVARTPublications
Legal/procedural statusVSTPublication by DPMA of mention regarding EP patent grant
Date of legal/procedural statusVSTTApr 19, 2018
Issue numberHN16
YearPJ2018
Publication dateVTApr 19, 2018
Type of publicationPARTBibliographic data
PartHTPart 5
View procedures Procedure relating to EP application (No.: 5)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTNo opposition to patent grant filed, or opposition proceedings at EPO completed without decision
Date of legal/procedural statusVSTTJan 2, 2019
Issue numberHN11
YearPJ2019
Publication dateVTMar 14, 2019
Type of publicationPARTBibliographic data
PartHTPart 3
View procedures New applicant/owner details (No.: 6)
INIDCriterionFieldContent Close details
Type of procedureVARTNew applicant/owner details
Legal/procedural statusVSTNew applicant/owner details
Date of legal/procedural statusVSTTJun 4, 2021
Issue numberHN28
YearPJ2021
Publication dateVTJul 15, 2021
Type of publicationPARTBibliographic data
PartHTPart 3
71/73Applicant/ownerINHTakeda Pharmaceutical Co. Ltd., Osaka, JP
71/73Previous applicant/ownerINHFBaxalta GmbH, Zug, CH, Baxalta Incorporated, Bannockburn, Ill., US
Date of update of the procedureREGTJul 15, 2021
View procedures New applicant/owner details (No.: 7)
INIDCriterionFieldContent Close details
Type of procedureVARTNew applicant/owner details
Legal/procedural statusVSTNew applicant/owner details
Date of legal/procedural statusVSTTJul 26, 2023
Issue numberHN35
YearPJ2023
Publication dateVTAug 31, 2023
Type of publicationPARTBibliographic data
PartHTPart 3
71/73Applicant/ownerINHTakeda Pharmaceutical Company Limited, Osaka-shi, Osaka, JP
71/73Previous applicant/ownerINHFTakeda Pharmaceutical Co. Ltd., Osaka, JP
Date of update of the procedureREGTAug 31, 2023